StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies gross margin

Gross margin is gross profit as a percentage of revenue.

AXIM Biotechnologies's gross margin for the twelve months ending Sep 30, 2021 was 100.0%. For fiscal 2019 it was 0.0%, against 95.6% the year before. The highest annual figure on record is 95.6% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 20190.0%−95.6
FY2018Dec 31, 201895.6%+85.7
FY2017Dec 31, 20179.9%+237.4
FY2016Dec 31, 2016-227.5%−225.0
FY2015Dec 31, 2015-2.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 202490.0%−10.0
Q2 FY2023Jun 30, 2023100.0%+0.0
Q3 FY2022Sep 30, 2022100.0%+100.0
Q3 FY2021Sep 30, 2021100.0%+25.7
Q2 FY2021Jun 30, 2021100.0%+0.8
Q1 FY2021Mar 31, 2021100.0%+51.0
Q4 FY2019Dec 31, 20190.0%−72.1
Q1 FY2019Mar 31, 201974.3%−13.7
Q4 FY2018Dec 31, 201899.2%+4.3
Q3 FY2018Sep 30, 201849.0%−34.2
Q2 FY2018Jun 30, 201872.1%+11.8
Q1 FY2018Mar 31, 201888.0%+197.1
Q4 FY2017Dec 31, 201794.8%+921.5
Q3 FY2017Sep 30, 201783.2%+125.5
Q2 FY2017Jun 30, 201760.2%+67.7
Q1 FY2017Mar 31, 2017-109.1%−100.4
Q4 FY2016Dec 31, 2016-826.7%−812.8
Q3 FY2016Sep 30, 2016-42.3%+9.6
Q2 FY2016Jun 30, 2016-7.5%−107.5
Q1 FY2016Mar 31, 2016-8.6%–
Q4 FY2015Dec 31, 2015-13.9%–
Q3 FY2015Sep 30, 2015-51.9%–
Q2 FY2015Jun 30, 2015100.0%–

More AXIM Biotechnologies figures

See a number that looks wrong?